William B. Walkup & Associates Inc. Acquires New Shares in CVS Health Co. (NYSE:CVS)

William B. Walkup & Associates Inc. bought a new position in shares of CVS Health Co. (NYSE:CVS) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 21,485 shares of the pharmacy operator’s stock, valued at approximately $1,269,000.

Several other institutional investors also recently bought and sold shares of CVS. Ables Iannone Moore & Associates Inc. bought a new position in shares of CVS Health in the 4th quarter valued at approximately $32,000. First Community Trust NA raised its position in shares of CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after purchasing an additional 302 shares during the period. Creekmur Asset Management LLC acquired a new stake in shares of CVS Health in the fourth quarter worth $34,000. Steph & Co. boosted its holdings in shares of CVS Health by 192.0% during the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 288 shares during the period. Finally, ORG Partners LLC grew its stake in CVS Health by 11,840.0% in the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock valued at $35,000 after buying an additional 592 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Up 4.0 %

Shares of NYSE:CVS opened at $61.38 on Monday. The company has a market capitalization of $77.05 billion, a PE ratio of 10.79, a P/E/G ratio of 0.81 and a beta of 0.53. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86. The company’s fifty day moving average is $58.20 and its 200-day moving average is $61.87. CVS Health Co. has a 52 week low of $52.77 and a 52 week high of $83.25.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.73 by $0.10. The firm had revenue of $91.23 billion for the quarter, compared to analysts’ expectations of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.21 earnings per share. Equities research analysts predict that CVS Health Co. will post 6.51 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.33%. The ex-dividend date is Monday, October 21st. CVS Health’s payout ratio is presently 46.75%.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the company. Barclays lowered their price target on CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 8th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a report on Monday, September 16th. Royal Bank of Canada reiterated an “outperform” rating and set a $68.00 price target on shares of CVS Health in a report on Wednesday, September 4th. Wells Fargo & Company raised their price objective on shares of CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a research note on Monday, August 12th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Eleven research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $72.10.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.